These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 32466780)

  • 1. Pharyngeal metastasis following living-donor liver transplantation for hepatocellular carcinoma: a case report and literature review.
    Tohyama T; Sakamoto K; Tamura K; Nakamura T; Watanabe J; Wakisaka H; Takada Y
    World J Surg Oncol; 2020 May; 18(1):109. PubMed ID: 32466780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Recurrent HCC After Liver Transplantation.
    Sarici B; Isik B; Yilmaz S
    J Gastrointest Cancer; 2020 Dec; 51(4):1197-1199. PubMed ID: 32839944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria.
    Lee EC; Kim SH; Shim JR; Park SJ
    Liver Transpl; 2018 Jan; 24(1):35-43. PubMed ID: 28885774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma with pharyngeal metastasis: report of a case.
    Nagao Y; Cho A; Yamamoto H; Kainuma O; Gunji H; Miyazaki A; Ozaki D
    Surg Today; 2008; 38(11):1060-2. PubMed ID: 18958569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
    Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
    Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
    Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
    Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical analysis of patients with hepatocellular carcinoma recurrence after living-donor liver transplantation.
    Na GH; Hong TH; You YK; Kim DG
    World J Gastroenterol; 2016 Jul; 22(25):5790-9. PubMed ID: 27433092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
    Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
    Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic value of multislice spiral CT and MRI in detection of tumor recurrence after liver transplantation for hepatocellular carcinoma].
    Wang J; He BJ; Jiang ZB; Zhang YQ; Shan H; Xiao R; Zhang JS; Luo L; Kuang SC; Chen GH; Yang Y
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):691-6. PubMed ID: 20021867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of treatment outcome between living donor liver transplantation and sorafenib for patients with hepatocellular carcinoma beyond the Milan criteria.
    Cho Y; Lee JH; Lee DH; Cho EJ; Yu SJ; Yi NJ; Lee KW; Kim YJ; Yoon JH; Suh KS
    Oncotarget; 2017 Jul; 8(29):47555-47564. PubMed ID: 28548930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of advanced hepatocellular carcinoma with lung, brain and lymph node metastases recurred 8 years after hepatectomy successfully treated by operation, radiation and systemic chemotherapy using S-1/CDDP].
    Kagawa K; Kawakami Y; Honda Y; Nakahara T; Tanaka M; Naeshiro N; Miyaki D; Nagaoki Y; Kawaoka T; Takaki S; Hiramatsu A; Waki K; Hyogo H; Aikata H; Takahashi S; Arihiro K; Sanetou H; Chayama K
    Nihon Shokakibyo Gakkai Zasshi; 2012 Aug; 109(8):1401-8. PubMed ID: 22863965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local therapy improvement of outcome in a patient with recurrent hepatocellular carcinoma after living donor liver transplantation: a case report.
    Shimokawa M; Itoh S; Ikegami T; Takeishi K; Harimoto N; Yamashita YI; Yoshizumi T; Kawanaka H; Shirabe K; Maehara Y
    Anticancer Res; 2015 Jun; 35(6):3525-9. PubMed ID: 26026120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Liver Transplantation for Hepatocellular Carcinoma Beyond the University of California San Francisco Criteria: A Single-center Experience.
    Victor DW; Monsour HP; Boktour M; Lunsford K; Balogh J; Graviss EA; Nguyen DT; McFadden R; Divatia MK; Heyne K; Ankoma-Sey V; Egwim C; Galati J; Duchini A; Saharia A; Mobley C; Gaber AO; Ghobrial RM
    Transplantation; 2020 Jan; 104(1):113-121. PubMed ID: 31233480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of living donor liver transplantation after locoregional treatment for hepatocellular carcinoma: an experience from a single institute.
    Inomata K; Yagi H; Hibi T; Shinoda M; Matsubara K; Abe Y; Kitago M; Obara H; Itano O; Kawachi S; Tanabe M; Wakabayashi G; Shimazu M; Kitagawa Y
    Surg Today; 2021 Mar; 51(3):350-357. PubMed ID: 32767130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcopenia as a predictor of post-transplant tumor recurrence after living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria.
    Kim YR; Park S; Han S; Ahn JH; Kim S; Sinn DH; Jeong WK; Ko JS; Gwak MS; Kim GS
    Sci Rep; 2018 May; 8(1):7157. PubMed ID: 29740069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Living-donor liver transplantation for hepatocellular carcinoma.
    Kaihara S; Kiuchi T; Ueda M; Oike F; Fujimoto Y; Ogawa K; Kozaki K; Tanaka K
    Transplantation; 2003 Feb; 75(3 Suppl):S37-40. PubMed ID: 12589138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living Donor Versus Deceased Donor Liver Transplantation for HCC.
    Doğan SM; Kutlutürk K
    J Gastrointest Cancer; 2020 Dec; 51(4):1104-1106. PubMed ID: 32833221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
    Lee KW; Yi NJ; Suh KS
    Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma with metastasis to the pharynx: report of a case.
    Oida Y; Ishii M; Dowaki S; Tobita K; Ohtani Y; Imaizumi T; Abe Y; Yamazaki H; Nakamura M; Makuuchi H
    Tokai J Exp Clin Med; 2005 Apr; 30(1):31-4. PubMed ID: 15952296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of hepatocellular carcinoma with multiple lung, spleen, and remnant liver metastasis successfully treated by combination chemotherapy with the novel oral DPD-inhibiting chemotherapeutic drug S-1 and interferon-alpha.
    Nakamura M; Nagano H; Wada H; Noda T; Ota H; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Monden M
    J Gastroenterol; 2006 Nov; 41(11):1120-5. PubMed ID: 17160524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.